ArticleFree radical biology & medicine2025
Skeletal muscle knockout of NAD(P)H oxidase 2 delays the development of isotonic diaphragm fatigue in mice.
Article in Free radical biology & medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Skeletal Muscle Redox Signaling in Health and Disease: From Molecular Mechanisms to Therapeutic Exercise Strategies.Antioxidants (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Mechanisms of skeletal muscle fatigue are commonly studied under isometric conditions, which exclude muscle shortening and limit physiological relevance. We developed a novel in vitro protocol to examine isotonic fatigue using afterload contractions that permits the study of additional active (velocity, power, work) and passive (stiffness, energy loss) mechanical properties of muscle. During the development of this protocol, we examined the impact of shortening load during afterload contractions on the development of fatigue, and observed a relationship where fatigue onset is more rapid and severe with larger shortening loads (30 % vs. 45 % vs. 60 % maximal isometric force). We then applied this protocol to investigate the contribution of NAD(P)H Oxidase 2 (Nox2) to fatigue development and recovery. Nox2 was deleted from skeletal muscle using the Cre-LoxP system (skmNox2KO), while Cre-negative littermates were used as controls. Knockout of Nox2 attenuated the decline in power and increased total isotonic work performed during repeated contractions compared to controls. Recovery kinetics of power, work, and isometric force were similar between groups. Passive mechanical properties-including stiffness and energy loss- increased with fatigue but were unaffected by Nox2 deletion. These findings highlight the importance of incorporating isotonic contractions to uncover fatigue mechanisms and suggest that Nox2, and presumably reactive oxygen species, contributes to the decline in muscle power during repetitive shortening contractions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.